CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ABBV

Trifluridine/Tipiracil

Phase 3
AbbVie Inc. (ABBV)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Aug '27
ABBVPhase 3

Telisotuzumab Adizutecan Phase 3 Est. Readout

Trifluridine/Tipiracil
Aug 2027~STALE
CT.gov
00%
Competitive Landscape
Drug Information

Target Indication

Metastatic Colorectal Cancer

Clinical Trial

NCT06614192

Last updated: 1/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.